Astaxanthin from Haematococcus pluvialis prevents oxidative stress on human endothelial cells without toxicity

Marine Drugs

Volumn 13, Issue 5, 2015, Pages 2857-2874

  Régnier, Philippe ^a   Bastias, Jorge ^b   Rodriguez Ruiz, Violeta ^a   Caballero Casero, Noelia ^c   Caballo, Carmen ^c   Sicilia, Dolores ^c   Fuentes, Axelle ^a   Maire, Murielle ^a   Crepin, Michel ^a   Letourneur, Didier ^a   Gueguen, Virginie ^a   Rubio, Soledad ^c   Pavon Djavid, Graciela ^a  

^a Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^b Área de Desarrollo Acuícola   (Chile)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Antioxidants; Astaxanthin; Haematococcus pluvialis; HUVEC; Oxidative stress; TEAC

Indexed keywords

ANTIOXIDANT; ASTAXANTHIN; CAROTENOID; XANTHOPHYLL;

ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; OXIDATIVE STRESS; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY ASSAY; ULTRAVIOLET SPECTROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; MICROALGA;

HAEMATOCOCCUS PLUVIALIS;

ANTIOXIDANTS; CAROTENOIDS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICROALGAE; OXIDATIVE STRESS; XANTHOPHYLLS;

EID: 84930645764     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13052857     Document Type: Article

References (49)

1. Ambati, R.R.; Phang, S.M.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications - A review. Mar. Drugs 2014, 12, 128-152.
2. Montezano, A.C.; Touyz, R.M. Molecular mechanisms of hypertension reactive oxygen species and antioxidants: A basic science update for the clinician. Can. J. Cardiol. 2012, 28, 288-295.
3. Ross, R. Atherosclerosis is an inflammatory disease. Am. Heart J. 1999, 138, S419-S420.
4. Shimokawa, H. Primary endothelial dysfunction: Atherosclerosis. J. Mol. Cell. Cardiol. 1999, 31, 23-37.
5. Bonnefont-Rousselot, D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5, 561-568.
6. Elliott, H.L. Endothelial dysfunction in cardiovascular disease: Risk factor, risk marker, or surrogate end point? J. Cardiovasc. Pharmacol. 1998, 32, S74-S77.
7. Landmesser, U.; Hornig, B.; Drexler, H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004, 109, II27-II33.
8. Verma, S.; Szmitko, P.E. The vascular biology of peroxisome proliferator-activated receptors: Modulation of atherosclerosis. Can. J. Cardiol. 2006, 22, 12B-17B.
9. El-Agamey, A.; Lowe, G.M.; McGarvey, D.J.; Mortensen, A.; Phillip, D.M.; Truscott, T.G.; Young, A.J. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. Biochem. Biophys. 2004, 430, 37-48.
10. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
11. Fassett, R.G.; Coombes, J.S. Astaxanthin: A potential therapeutic agent in cardiovascular disease. Mar. Drugs 2011, 9, 447-465.
12. Pashkow, F.J.; Watumull, D.G.; Campbell, C.L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101, 58D-68D.
13. EFSA. Scientific Opinion on the Safety and Efficacy of Astaxanthin (Carophyll® Pink 10% CWS) for Salmonids and Ornamental Fish; European Food Safety Authority (EFSA): Parma, Italy, 2014; pp. 3724-3759.
14. Fassett, R.G.; Coombes, J.S. Astaxanthin in cardiovascular health and disease. Molecules 2012, 17, 2030-2048.
15. Sasaki, Y.; Kobara, N.; Higashino, S.; Giddings, J.C.; Yamamoto, J. Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats. Nutr. Res. 2011, 31, 784-789.
16. Yoshida, H.; Yanai, H.; Ito, K.; Tomono, Y.; Koikeda, T.; Tsukahara, H.; Tada, N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010, 209, 520-523.
17. Adluri, R.S.; Thirunavukkarasu, M.; Zhan, L.; Maulik, N.; Svennevig, K.; Bagchi, M.; Maulik, G. Cardioprotective efficacy of a novel antioxidant mix vitaepro against ex vivo myocardial ischemia-reperfusion injury. Cell Biochem. Biophys. 2013, 67, 281-286.
18. Lauver, D.A.; Booth, E.A.; White, A.J.; Poradosu, E.; Lucchesi, B.R. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J. Pharmacol. Exp. Ther. 2005, 312, 794-800.
19. Ryu, S.K.; King, T.J.; Fujioka, K.; Pattison, J.; Pashkow, F.J.; Tsimikas, S. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and apoe(-/-) mice. Atherosclerosis 2012, 222, 99-105.
20. Khan, S.K.; Malinski, T.; Mason, R.P.; Kubant, R.; Jacob, R.F.; Fujioka, K.; Denstaedt, S.J.; King, T.J.; Jackson, H.L.; Hieber, A.D.; et al. Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thrombosis Res. 2010, 126, 299-305.
21. Hussein, G.; Sankawa, U.; Goto, H.; Matsumoto, K.; Watanabe, H. Astaxanthin, a carotenoid with potential in human health and nutrition. J. Nat. Prod. 2006, 69, 443-449.
22. Chiou, T.H.; Place, A.R.; Caldwell, R.L.; Marshall, N.J.; Cronin, T.W. A novel function for a carotenoid: Astaxanthin used as a polarizer for visual signalling in a mantis shrimp. J. Exp. Biol. 2012, 215, 584-589.
23. Deroche, M.E.; Briantais, J.M. Absorption spectra of chlorophyll forms, β-carotene and lutein in freeze-dried chloroplasts. Photochem. Photobiol. 1974, 19, 233-240.
24. Miao, F.; Lu, D.; Li, Y.; Zeng, M. Characterization of astaxanthin esters in Haematococcus pluvialis by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Anal. Biochem. 2006, 352, 176-181.
25. Chang, C.S.; Chang, C.L.; Lai, G.H. Reactive oxygen species scavenging activities in a chemiluminescence model and neuroprotection in rat pheochromocytoma cells by astaxanthin, β-carotene, and canthaxanthin. Kaohsiung J. Med. Sci. 2013, 29, 412-421.
26. Naguib, Y.M. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48, 1150-1154.
27. Jaime, L.; Rodríguez-Meizoso, I.; Cifuentes, A.; Santoyo, S.; Suarez, S.; Ibáñez, E.; Señorans, F.J. Pressurized liquids as an alternative process to antioxidant carotenoids' extraction from Haematococcus pluvialis microalgae. LWT Food Sci. Technol. 2010, 43, 105-112.
28. Reyes, F.A.; Mendiola, J.A.; Ibañez, E.; del Valle, J.M. Astaxanthin extraction from Haematococcus pluvialis using CO2-expanded ethanol. J. Supercrit. Fluids 2014, 92, 75-83.
29. Capelli, B.; Bagchi, D.; Cysewski, G.R. Synthetic astaxanthin is significantly inferior to algal-based astaxanthin as an antioxidant and may not be suitable as a human nutraceutical supplement. Nutrafoods 2013, 12, 145-152.
30. Miki, W. Biological functions and activities of animal carotenoids. Pure Appl. Chem. 1991, 63, 141-146.
31. Ceron, M.C.; Garcia-Malea, M.C.; Rivas, J.; Acien, F.G.; Fernandez, J.M.; del Rio, E.; Guerrero, M.G.; Molina, E. Antioxidant activity of Haematococcus pluvialis cells grown in continuous culture as a function of their carotenoid and fatty acid content. Appl. Microbiol. Biotechnol. 2007, 74, 1112-1119.
32. Kobayashi, M.; Sakamoto, Y. Singlet oxygen quenching ability of astaxanthin esters from the green alga Haematococcus pluvialis. Biotechnol. Lett. 1999, 21, 265-269.
33. Huang, D.; Ou, B.; Prior, R.L. The chemistry behind antioxidant capacity assays. J. Agric. Food Chem. 2005, 53, 1841-1856.
34. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
35. Nagaraj, S.; Rajaram, M.G.; Arulmurugan, P.; Baskaraboopathy, A.; Karuppasamy, K.; Jayappriyan, K.R.; Sundararaj, R.; Rengasamy, R. Antiproliferative potential of astaxanthin-rich alga Haematococcus pluvialis flotow on human hepatic cancer (HEPG2) cell line. Biomed. Prevent. Nutr. 2012, 2, 149-153.
36. Girard-Lalancette, K.; Pichette, A.; Legault, J. Sensitive cell-based assay using dcfh oxidation for the determination of pro- and antioxidant properties of compounds and mixtures: Analysis of fruit and vegetable juices. Food Chem. 2009, 115, 720-726.
37. Oueslati, S.; Trabelsi, N.; Boulaaba, M.; Legault, J.; Abdelly, C.; Ksouri, R. Evaluation of antioxidant activities of the edible and medicinal suaeda species and related phenolic compounds. Ind. Crops Prod. 2012, 36, 513-518.
38. Yang, H.-L.; Chen, S.-C.; Lin, K.-Y.; Wang, M.-T.; Chen, Y.-C.; Huang, H.-C.; Cho, H.-J.; Wang, L.; Kumar, K.J.S.; Hseu, Y.-C. Antioxidant activities of aqueous leaf extracts of toona sinensis on free radical-induced endothelial cell damage. J. Ethnopharmacol. 2011, 137, 669-680.
39. Fedotcheva, N.I.; Mokhova, E.N. Mechanism of induction of oxidative stress in liver mitochondria by low concentrations of tert-butyl hydroperoxide. Biochem. Biokhimiia 2013, 78, 75-79.
40. Kucera, O.; Endlicher, R.; Rousar, T.; Lotkova, H.; Garnol, T.; Drahota, Z.; Cervinkova, Z. The effect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro. Oxid. Med. Cell Longev. 2014, 2014, 752506.
41. Frankel, E.N.; Meyer, A.S. The problems of using one-dimensional methods to evaluate multifunctional food and biological antioxidants. J. Sci. Food Agric. 2000, 80, 1925-1941.
42. Guerra, B.A.; Otton, R. Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose. Int. Immunopharmacol. 2011, 11, 2220-2226.
43. Asikin, Y.; Takahashi, M.; Mishima, T.; Mizu, M.; Takara, K.; Wada, K. Antioxidant activity of sugarcane molasses against 2,2′-azobis(2-amidinopropane) dihydrochloride-induced peroxyl radicals. Food Chem. 2013, 141, 466-472.
44. Ou, B.; Hampsch-Woodill, M.; Prior, R.L. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem. 2001, 49, 4619-4626.
45. Zulueta, A.; Esteve, M.J.; Frígola, A. Orac and teac assays comparison to measure the antioxidant capacity of food products. Food Chem. 2009, 114, 310-316.
46. Nishigaki, I.; Rajendran, P.; Venugopal, R.; Ekambaram, G.; Sakthisekaran, D.; Nishigaki, Y. Cytoprotective role of astaxanthin against glycated protein/iron chelate-induced toxicity in human umbilical vein endothelial cells. Phytother. Res. PTR 2010, 24, 54-59.
47. Juni, R.P.; Duckers, H.J.; Vanhoutte, P.M.; Virmani, R.; Moens, A.L. Oxidative stress and pathological changes after coronary artery interventions. J. Am. Coll. Cardiol. 2013, 61, 1471-1481.
48. Hamilos, M.I.; Ostojic, M.; Beleslin, B.; Sagic, D.; Mangovski, L.; Stojkovic, S.; Nedeljkovic, M.; Orlic, D.; Milosavljevic, B.; Topic, D.; et al. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J. Am. Coll. Cardiol. 2008, 51, 2123-2129.
49. Togni, M.; Raber, L.; Cocchia, R.; Wenaweser, P.; Cook, S.; Windecker, S.; Meier, B.; Hess, O.M. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int. J. Cardiol. 2007, 120, 212-220.